BNR logo

BNR Stock Overview

Profile

Full Name:

Burning Rock Biotech Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

China

IPO:

June 12, 2020

Indexes:

Not included

Website:

http://www.brbiotech.com

Description:

Burning Rock Biotech Limited is a biotechnology company focused on developing and providing advanced genomic testing services. They specialize in cancer detection and monitoring through innovative technologies, helping patients and healthcare providers make informed decisions based on genetic information. Their goal is to improve cancer care and outcomes.

Key Details

Price

$5.22

Market Cap

$53.55 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$75.98 M(-9.39% YoY)

Annual EPS

-$9.02(+35.20% YoY)

PE Ratio

-

Annual ROE

-66.89%

Annual Debt To Equity

0.00

Beta

1.07

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Dec 3, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 15, 2024

Analyst ratings

Recent major analysts updates

Jul 14, 21 CICC
Outperform
Jul 13, 20 B of A Securities
Buy
Jul 7, 20 Cowen & Co.
Outperform

Screeners with BNR included

Growing Shares Outstanding
Chinese stocks
Healthcare sector
All stocks
Small cap stocks
Diagnostics & Research industry
Stocks with high beta
NASDAQ earnings calendar
Stocks below SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.22
BNR price is $5.22

Price All-time High

$395.80
BNR price is currently -98.68% below its historical high of $395.80

Price Analysts Target

-
BNR price consensus analysts' forecast is unknown

Price Today Change

+0.77%
BNR price is up +0.77% today

Price YTD Change

-22.67%
BNR price is down -22.67% since January 1st

Price 3-Year Change

-93.05%
BNR price is down -93.05% over the past 3 years

Market cap

Market Cap

$53.55 M
BNR market capitalization is $53.55 million

Market Cap 3-Year Change

-93.22%
BNR market capitalization is down -93.22% over the past 3 years

Market Cap All-time High

$4.14 B
BNR market capitalization is currently -98.71% below its historical high of $4.14 billion

Market Cap Sector Rank

36.79%
BNR market capitalization is higher than 36.79% of companies in Healthcare sector

Technical

Beta

1.07
BNR beta is 1.07

200-day SMA

$5.78
BNR price is currently -9.70% below its 200-day simple moving average

14-day RSI

34.30
BNR 14-day relative strength index is 34.30

30-day Relative Volume

0.11
BNR 30-day relative volume is 0.11

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$75.98 M
BNR annual revenue is $75.98 million

Annual Revenue Analysts Estimate

$109.30 M
BNR annual revenue is currently -30.49% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-9.39%
BNR annual revenue is down -9.39% year-on-year

Annual Revenue Sector Rank

53.69%
BNR annual revenue is higher than 53.69% of companies in Healthcare sector

Profit

Annual Gross Profit

$51.35 M
BNR annual gross profit is $51.35 million

Annual Gross Margin

67.59%
BNR annual gross profit margin is 67.59%

Annual Operating Profit

-$94.62 M
BNR annual operating income is -$94.62 million

Annual Operating Margin

-124.54%
BNR annual operating profit margin is -124.54%

Annual Net Income

-$92.41 M
BNR annual net profit is -$92.41 million

Annual Net Margin

-121.63%
BNR annual net profit margin is -121.63%

EPS

Annual EPS

-$9.02
BNR annual earnings per share is -$9.02

Annual EPS Analysts Estimate

-
BNR annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+35.2%
BNR annual earnings per share is up +35.2% year-on-year

Annual EPS Sector Rank

16.15%
BNR annual earnings per share is higher than 16.15% of companies in Healthcare sector

ROA & ROE

Annual ROA

-49.05%
BNR annual return on assets is -49.05%

Annual ROE

-66.89%
BNR annual return on equity is -66.89%

EBIT & EBITDA

Annual EBIT

-$92.07 M
BNR annual earnings before interest & taxes is -$92.07 million

Annual EBITDA

-$92.07 M
BNR annual EBITDA is -$92.07 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BNR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BNR price to earnings ratio is unknown

PB Ratio

PB Ratio

0.58
BNR price to book ratio is 0.58

PB Ratio Sector Rank

31.35%
BNR price to book ratio is higher than 31.35% of companies in Healthcare sector

PS Ratio

PS Ratio

0.75
BNR price to sales ratio is 0.75

PS Ratio Sector Rank

21.04%
BNR price to sales ratio is higher than 21.04% of companies in Healthcare sector

Enterprise value

Enterprise Value

-$3.07 M
BNR enterprise value is -$3.07 million

Enterprise Value Sector Rank

7.85%
BNR enterprise value is higher than 7.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.05
BNR EV/EBITDA is 0.05

EV/EBITDA Sector Rank

66.73%
BNR EV/EBITDA is higher than 66.73% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.36
BNR annual current ratio is 3.36

Annual Quick Ratio

3.09
BNR annual quick ratio is 3.09

Leverage

Annual Debt To Equity

0.00
BNR annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
BNR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
BNR piotroski f-score is 4

Altman Z-Score

-5.19
BNR altman z-score is -5.19

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$146.72 M
BNR annual total assets is $146.72 million

Annual Non Current Assets

$21.99 M
BNR annual long term assets is $21.99 million

Annual Current Assets

$124.72 M
BNR annual total current assets is $124.72 million

Annual Cash & Cash Equivalents

$86.77 M
BNR annual cash & cash equivalents is $86.77 million

Equity

Annual Book Value

$108.40 M
BNR annual book value is $108.40 million

Annual Working Capital

$87.57 M
BNR annual working capital is $87.57 million

Liabilities

Annual Total Liabilities

$38.31 M
BNR annual total liabilities is $38.31 million

Annual Total Long Term Liabilities

$1.16 M
BNR annual total long term liabilities is $1.16 million

Annual Current Liabilities

$37.15 M
BNR annual total current liabilities is $37.15 million

Annual Accounts Payable

$2.55 M
BNR annual accounts payable is $2.55 million

Debt

Annual Total Debt

$1.74 M
BNR annual total debt is $1.74 million

Annual Total Debt 1-Year Change

-76.38%
BNR annual total debt is down -76.38% year-on-year

Annual Long Term Debt

$520.60 K
BNR annual long term debt is $520.60 thousand

Annual Short Term Debt

$1.22 M
BNR annual short term debt is $1.22 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$170.60 M
BNR annual total expenses is $170.60 million

Annual Operating Expenses

$145.97 M
BNR annual total operating expenses is $145.97 million

Annual Cost Of Goods Sold

$24.63 M
BNR annual cost of goods sold is $24.63 million

Annual SGA

$96.91 M
BNR annual SGA is $96.91 million

Annual D&A

$18.86 M
BNR annual depreciation & amortization is $18.86 million

Annual Interest Expense

$0.00
BNR annual interest expense is $0.00

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$36.16 M
BNR annual cash flow from operations is -$36.16 million

Annual CFO 1-Year Change

+46.83%
BNR annual cash flow from operations is up +46.83% year-on-year

Annual CFI

-$1.31 M
BNR annual cash flow from investing activities is -$1.31 million

Annual CFI 1-Year Change

-18.32%
BNR annual cash flow from investing activities is down -18.32% year-on-year

Annual CFF

-$6.90 M
BNR annual cash flow from financing activities is -$6.90 million

Annual CFF 1-Year Change

+46.23%
BNR annual cash flow from financing activities is up +46.23% year-on-year

Free CashFlow

Annual FCF

-$36.16 M
BNR annual free cash flow is -$36.16 million

Annual FCF 1-Year Change

+53.94%
BNR annual free cash flow is up +53.94% year-on-year

CAPEX

Annual CAPEX

$1.33 M
BNR annual capital expenditures is $1.33 million

Annual CAPEX 1-Year Change

-87.36%
BNR annual capital expenditures is down -87.36% year-on-year

Institutional Ownership

Similar stocks

SCLX logo
Scilex Holding (SCLX)
RGC logo
Regencell Bioscience Holdings Limited (RGC)
ONCY logo
Oncolytics Biotech (ONCY)
NVNO logo
enVVeno Medical (NVNO)
OCX logo
OncoCyte (OCX)
KPTI logo
Karyopharm Therapeutics (KPTI)
BEAT logo
HeartBeam (BEAT)
UNCY logo
Unicycive Therapeutics (UNCY)
GANX logo
Gain Therapeutics (GANX)

FAQ

  • What is the ticker symbol for Burning Rock Biotech Limited?
  • Does Burning Rock Biotech Limited pay dividends?
  • What sector is Burning Rock Biotech Limited in?
  • What industry is Burning Rock Biotech Limited in?
  • What country is Burning Rock Biotech Limited based in?
  • When did Burning Rock Biotech Limited go public?
  • Is Burning Rock Biotech Limited in the S&P 500?
  • Is Burning Rock Biotech Limited in the NASDAQ 100?
  • Is Burning Rock Biotech Limited in the Dow Jones?
  • When was Burning Rock Biotech Limited's last earnings report?
  • When does Burning Rock Biotech Limited report earnings?

What is the ticker symbol for Burning Rock Biotech Limited?

The ticker symbol for Burning Rock Biotech Limited is NASDAQ:BNR

Does Burning Rock Biotech Limited pay dividends?

No, Burning Rock Biotech Limited does not pay dividends

What sector is Burning Rock Biotech Limited in?

Burning Rock Biotech Limited is in the Healthcare sector

What industry is Burning Rock Biotech Limited in?

Burning Rock Biotech Limited is in the Diagnostics & Research industry

What country is Burning Rock Biotech Limited based in?

Burning Rock Biotech Limited is headquartered in China

When did Burning Rock Biotech Limited go public?

Burning Rock Biotech Limited's initial public offering (IPO) was on June 12, 2020

Is Burning Rock Biotech Limited in the S&P 500?

No, Burning Rock Biotech Limited is not included in the S&P 500 index

Is Burning Rock Biotech Limited in the NASDAQ 100?

No, Burning Rock Biotech Limited is not included in the NASDAQ 100 index

Is Burning Rock Biotech Limited in the Dow Jones?

No, Burning Rock Biotech Limited is not included in the Dow Jones index

When was Burning Rock Biotech Limited's last earnings report?

Burning Rock Biotech Limited's most recent earnings report was on Dec 3, 2024

When does Burning Rock Biotech Limited report earnings?

The next expected earnings date for Burning Rock Biotech Limited is Mar 28, 2025